Bronchial hyperreactivity and spirometric impairment in polysensitized patients with allergic rhinitis by Ciprandi, Giorgio et al.
BioMed  Central
Page 1 of 6
(page number not for citation purposes)
Clinical and Molecular Allergy
Open Access Research
Bronchial hyperreactivity and spirometric impairment in 
polysensitized patients with allergic rhinitis
Giorgio Ciprandi*1, Ignazio Cirillo2, Maria A Tosca3 and Andrea Vizzaccaro2
Address: 1Allergy, Head-Neck Department, San Martino Hospital, Genoa, Italy, 2Medicine Department, Navy Hospital, La Spezia, Italy and 
3Pediatrics Department, Istituto Giannina Gaslini, Genoa, Italy
Email: Giorgio Ciprandi* - gio.cip@libero.it; Ignazio Cirillo - drcirillo@libero.it; Maria A Tosca - MariangelaTosca@ospedale-gaslini.ge.it; 
Andrea Vizzaccaro - vizzaccaro@libero.it
* Corresponding author    
allergic rhinitispolysensitizationbronchial hyperreactivitymethacholine challengeFEF 25–75
Abstract
Background: We previously demonstrated in a group of patients with perennial allergic rhinitis
alone impairment of spirometric parameters and high percentage of subjects with bronchial
hyperreactivity (BHR). The present study aimed at evaluating a group of polysensitized subjects
suffering from allergic rhinitis alone to investigate the presence of spirometric impairment and BHR
during the pollen season.
Methods: One hundred rhinitics sensitized both to pollen and perennial allergens were evaluated
during the pollen season. Spirometry and methacholine bronchial challenge were performed.
Results: Six rhinitics showed impaired values of FEV1 without referred symptoms of asthma. FEF
25–75 values were impaired in 28 rhinitics. Sixty-six patients showed positive methacholine
bronchial challenge. FEF 25–75 values were impaired only in BHR positive patients (p < 0.001). A
significant difference was observed both for FEV1 (p < 0.05) and FEF 25–75 (p < 0.001) considering
BHR severity.
Conclusions:  This study evidences that an impairment of spirometric parameters may be
observed in polysensitized patients with allergic rhinitis alone during the pollen season. A high
percentage of these patients had BHR. A close relationship between upper and lower airways is
confirmed.
Background
Close association between allergic rhinitis and asthma has
been demonstrated by several studies [1-3]. Moreover,
allergic rhinitis has been demonstrated to be a strong risk
factor for the onset of asthma in adults [4].
Asthma is characterized by a reversible airflow obstruction
and forced expiratory volume/1 second (FEV1) is consid-
ered the main parameter to evaluate bronchial obstruc-
tion [5]. Nevertheless, there is increasing interest to
consider the involvement of small airways in the patho-
genesis of asthma [6]. Even though there is no direct
parameter cap able of assessing small airways, it has been
assumed that the forced expiratory flow at the 25 and 75%
of the pulmonary volume (FEF 25–75) might be consid-
ered as a measure of the caliber concerning distal airways
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[7]. Particularly, subjects with mild asthma and normal
FEV1 may show impaired FEF 25–75 only [8]. On the
other hand, bronchial hyperreactivity (BHR) is a para-
mount feature of asthma. Moreover, BHR may be
observed in a proportion of rhinitics [9]. In this regard, it
has been hypothesized that a positive bronchial challenge
to methacholine could be considered as predictive for
those rhinitics would progress to develop asthma [10]. In
addition, a seasonal variability in BHR was described in
subjects sensitized to pollens [11]. Very recently, we dem-
onstrated that patients with perennial allergic rhinitis
alone frequently showed impaired spirometric parameters
and positive methacholine challenge [12].
On the basis of these considerations, we aimed at evaluat-
ing a group of polysensitized patients with allergic rhinitis
alone to investigate the presence of spirometric abnormal-
ities and BHR during the pollen season.
Materials and methods
Study design
The study was performed during the pollen season (when
patients were symptomatic), from April to May. To evalu-
ate spirometric abnormalities and the presence of BHR in
patients with pure rhinitis, we included subjects with
allergic rhinitis due both to pollen and perennial aller-
gens. We excluded all the subjects who met the following
exclusion criteria: asthma symptoms, including cough,
wheezing, dyspnoea, chest tightness, and shortness of
breathing, acute upper respiratory infections and use of
nasal or oral corticosteroids, and antihistamines within
the previous 4 weeks.
The study was approved by the Institutional Review Board
of Navy Hospital, an informed consent was obtained from
patients, and was in compliance with the Helsinki
Declaration.
Subjects
One hundred rhinitic patients were prospectively and
consecutively evaluated, all males, age 23.4 ± 3.8 years. All
of them were Navy soldiers who referred to Navy Hospital
for periodic fitness visit. All of them were evaluated per-
forming both spirometry and methacholine bronchial
challenge during the pollen season, i.e. in the spring, sea-
son with pollens in our geographic area [3].
A detailed clinical history and a complete physical exami-
nation, including allergy evaluation, were performed. The
patients were included in the study on the basis of a clin-
ical history of allergic rhinitis. All patients were sensitized
both to pollens (i.e. Parietaria officinalis, grasses, olive tree,
birch, or hazel) and perennial allergens (i.e. house dust
mites, cat, or dog). The diagnosis of allergic rhinitis was
made on the basis of a history of nasal symptoms and pos-
itive skin prick test as described elsewhere [3]. None of the
patients was a previous or a current smoker.
Skin prick test
it was performed as stated by the Italian Society of Allergy
and Clinical Immunology [13]. The panel consisted of:
house dust mites (Dermatophagoides farinae and pteronyssi-
nus), cat, dog, grasses mix, Compositae mix, Parietaria offic-
inalis, birch, hazel, olive tree, Alternaria Tenuis,
Cladosporium, Aspergilli mix (Stallergenes, Milan, Italy).
Spirometry
It was performed by using a computer-assisted spirometer
(Pulmolab 435-Spiro 235, Morgan, England), with opto-
electronic whirl flow meter. Spirometry is performed as
stated by European respiratory Society [14], using the
European Community for Steel and Coal reference
equations.
If an airway obstruction was present as detected by FEV1
values less than 80% of the predicted, a test of bronchodil-
atation was performed using a salbutamol metered dose
of 200 mcg. Reversibility was considered if an increase of
at least 12% of FEV1 from baseline was achieved, accord-
ing to international guidelines [15].
Methacholine bronchial challenge
It was performed to evaluate BHR only if basal FEV1 was
equal or more than 80% of predicted. Aerosol is delivered
using a dosimetric computerized supply (MEFAR MB3,
Marcos, Italy). Subjects inhaled increasing doses of meth-
acholine, starting from 34 µg/mL. The scheduled doses
consisted of the following: 34, 68, 68, 68, 170, 170, 340,
170, 340, 170 µg/mL as previously reported [3,12].
The test was interrupted when FEV1 value was reduced by
more or equal than 20% of control or a maximal cumula-
tive dose of 1,598 µg/ml was achieved. The threshold dose
causing a 20% fall of FEV1 (PD20) was calculated.
Degree of BHR
Four arbitrary classes of BHR were considered: very mild =
PD20 > 400 µg/mL, mild = PD20 ranging from 201 to 400
µg/mL, moderate = PD20 ranging from 200 to 101 µg/mL,
and severe = PD20 < 100 µg/mL as previously reported
[6,16].
Statistical analysis
Statistical analysis was performed using X square test, cal-
culating confidential limits of the relative risk at 95%. Dif-
ferences were considered significant if p values were
<0.05. Data are presented as means.Clinical and Molecular Allergy 2004, 2 http://www.clinicalmolecularallergy.com/content/2/1/3
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Results
All rhinitics were consecutive subjects meeting the inclu-
sion and exclusion criteria and agreeing to join the study.
No adverse event was reported during the study.
Sensitizations
all subjects were sensitized both to perennial allergens
and pollen allergens. Twenty subjects had 2 sensitizations,
34 had 3 sensitizations, and 46 had more than 3 sensiti-
zations. There was no relationship between number of
sensitizations and spirometric data.
Spirometry
six patients showed a FEV1 value less than 80% of the pre-
dicted. It has to be mentioned that all of them were com-
pletely asymptomatic for complaints concerning lower
airways. A bronchial reversibility was achieved in all
subjects.
In addition, 7 patients showed impaired FVC values and
28 patients showed abnormal FEF 25–75 values.
Methacholine bronchial challenge
it was performed in 94 rhinitics. Sixty-six rhinitics showed
a positive methacholine challenge. On the basis of BHR
degree, we subdivided the methacholine positive patients
in 4 groups: very mild, mild, moderate, and severe. Seven-
teen patients had a very mild degree of BHR, 16 had a
mild degree, 10 had a moderate degree, and 23 a severe
degree.
Then, we analyzed subjects subdividing them in two
groups: patients with BHR (BHR positive group) and
patients without BHR (BHR negative group). Thus, we
evaluated the distribution of the patients considering
FEV1, FVC, and FEF 25–75 values (Figure 1). FEV1 values
were normal in both groups. Five subjects in the BHR pos-
itive group and 2 in the BHR negative group had reduced
values of FVC only. FEF 25–75 values were reduced in 28
subjects of BHR positive group only (p < 0.001).
We considered the three spirometric parameters related
with BHR degree (Figure 2). A significant difference was
observed for both FEV1 and FEF 25–75 considering BHR
severity in subjects with moderate BHR (p < 0.001 for FEF
25–75 only) and with severe BHR (p < 0.05 for FEV1 and
p < 0.001 for FEF 25–75).
Discussion
Allergic rhinitis and asthma should be considered as a sin-
gle syndrome involving two parts of the respiratory tract,
even though it is evident that these two disorders affect
each other [16].
Allergic rhinitics frequently present a non-specific BHR
even in absence of asthmatic symptoms. In these subjects
with normal FEV1 values, BHR may be envisaged as a
marker of susceptibility to develop asthma. On the other
hand, in mild asthmatics during intercritical periods lung
function may be normal concerning FEV1 values [17].
Moreover, asthma is a chronic inflammatory disease of
airways and using other parameters it has been demon-
strated a persistence of inflammation, also in absence of
symptoms, mainly involving smaller airways [18]. In
these cases, abnormal FEF 25–75 values may be observed:
it has been reported that FEF 25–75 may be reduced in
asthmatics with normal FEV1 and FVC values [8]. It has
been suggested that FEF 25–75 might be considered a
marker of small airways impairment in mild asthmatics
with normal FVC values [7].
Very recently, we demonstrated some interesting findings
in a group of 100 patients with perennial allergic rhinitis
alone [12]. Five patients showed impaired FEV1 values
(<80% of predicted), without any perceived lower respira-
tory symptoms [12]. Moreover, 72 patients showed posi-
tive methacholine challenge, and there was a significant
relationship between BHR degree and FEV1 and FEF 25–
75 values [12]. Thus, we aimed at investigating a large
group of polysensitized patients with allergic rhinitis dur-
ing the pollen season to evaluate spirometry and BHR.
The present findings suggest some considerations con-
cerning the link between upper and lower airways.
Firstly, evaluating a large cohort of polysensitized subjects
with allergic rhinitis alone, it is possible to single out
some subjects (six) with overt bronchial obstruction, as
documented by impaired FEV1 values. These patients may
be considered as "poor perceiver" of their lower respira-
tory symptoms. In fact, all of them had a normal life play-
ing different sports without trouble. In addition, they
never felt lower respiratory symptoms nor diagnosis of
asthma has been made. It is noteworthy that this finding
confirms that demonstrated in perennial rhinitics (5
patients with overt bronchial obstruction).
Secondly, most of our rhinitics (66 subjects) showed
BHR. This finding is not surprising if compared with liter-
ature analysis and confirm our previous findings in
patients with perennial allergic rhinitis. The exposure to
allergens is characterized by nasal inflammation as previ-
ously described by ourselves [19]. This concept may be
consistent with a consequent bronchial inflammation. It
is noteworthy that BHR was asymptomatic in all our
rhinitics.
Thirdly, considering the evaluation of FEF 25–75 parame-
ter we demonstrated that some rhinitics (28 subjects)Clinical and Molecular Allergy 2004, 2 http://www.clinicalmolecularallergy.com/content/2/1/3
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shows an initial level of bronchial obstruction during the
pollen season. It has to be highlighted that BHR positive
patients only showed this impairment. This finding may
underline the relevance of considering this parameter as it
was impaired only in BHR subjects. Thus, FEF 25–75
could be envisaged as marker of bronchial involvement in
pure rhinitics with BHR.
Fourthly, there is a relationship between degree of BHR
and FEV1 and FEF 25–75 impairment. These last findings
underline the relationship between BHR and airway cal-
iber in patients with airway inflammation. Moreover,
these data, taken together, partially confirm previous
results observed in patients with perennial allergic rhinitis
alone [12]. Polysensitized patients with allergic rhinitis,
compared with patients with perennial allergic rhinitis,
even more show an association with asthma, the impair-
ment of FEF 25–75, the BHR, and the relationship
between BHR grade and spirometric abnormalities. Actu-
ally, it is clear that allergic inflammation is chronic in
these subjects and it is exacerbated by pollen exposure.
Conclusions
The present study highlights the frequent coexistence of
bronchial impairment in polysensitized patients with
allergic rhinitis alone during the pollen season and sup-
ports the strong link between upper and lower airways.
Thus, a careful evaluation of lower airways should be per-
formed also in those patients with allergic rhinitis alone.
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